InsiderTrades.com logo
Chad Gassert net worth and biography
  • Phone
  • Email
  • Website

Chad Gassert Biography and Net Worth

Senior Vice President, Corporate Development and Strategy of ANI Pharmaceuticals

Mr. Gassert joined ANI in November 2021, through ANI's acquisition of Novitium Pharma, where he was Co-Founder and CEO. At Novitium, Mr. Gassert led the build out of a fully integrated generic pharmaceutical company focused on research & development, manufacturing, and distribution of prescription products. Prior to Novitium, Mr. Gassert worked at Par Pharmaceuticals from 2005 to 2016, where he held positions of increasing responsibility, including Senior Vice President of Business Development. In this role, Mr. Gassert headed corporate and business development activities including mergers and acquisitions, partnerships and licensing, portfolio management, project management and strategic sourcing teams. Prior to Par, Mr. Gassert worked at Sandoz and Wyeth as both a formulation and technical services scientist. Mr. Gassert holds a B.S. in nutritional science from the University of Delaware.

What is Chad Gassert's net worth?

The estimated net worth of Chad Gassert is at least $13.06 million as of July 1st, 2024. Mr. Gassert owns 193,226 shares of ANI Pharmaceuticals stock worth more than $13,064,010 as of March 30th. This net worth evaluation does not reflect any other investments that Mr. Gassert may own. Additionally, Mr. Gassert receives an annual salary of $849,710.00 as Senior Vice President, Corporate Development and Strategy at ANI Pharmaceuticals. Learn More about Chad Gassert's net worth.

How old is Chad Gassert?

Mr. Gassert is currently 48 years old. There are 8 older executives and no younger executives at ANI Pharmaceuticals. The oldest executive at ANI Pharmaceuticals is Mr. James G. Marken, Senior Vice President of Operations, who is 61 years old. Learn More on Chad Gassert's age.

What is Chad Gassert's salary?

As the Senior Vice President, Corporate Development and Strategy of ANI Pharmaceuticals, Inc., Mr. Gassert earns $849,710.00 per year. There are 4 executives that earn more than Mr. Gassert. The highest earning executive at ANI Pharmaceuticals is Mr. Nikhil Lalwani, President, CEO & Director, who commands a salary of $2,320,000.00 per year. Learn More on Chad Gassert's salary.

How do I contact Chad Gassert?

The corporate mailing address for Mr. Gassert and other ANI Pharmaceuticals executives is 210 Main Street West, Baudette MN, 56623. ANI Pharmaceuticals can also be reached via phone at (218) 634-3500 and via email at ir@anipharmaceuticals.com. Learn More on Chad Gassert's contact information.

Has Chad Gassert been buying or selling shares of ANI Pharmaceuticals?

Chad Gassert has not been actively trading shares of ANI Pharmaceuticals during the last quarter. Most recently, Chad Gassert sold 20,000 shares of the business's stock in a transaction on Monday, July 1st. The shares were sold at an average price of $63.44, for a transaction totalling $1,268,800.00. Following the completion of the sale, the senior vice president now directly owns 193,226 shares of the company's stock, valued at $12,258,257.44. Learn More on Chad Gassert's trading history.

Who are ANI Pharmaceuticals' active insiders?

ANI Pharmaceuticals' insider roster includes Stephen Carey (CFO), Stephen Carey (Senior Vice President, Finance and Chief Financial Officer), Meredith Cook (Senior Vice President, General Counsel and Corporate Secretary), Krista Davis (Senior Vice President and Chief Human Resources Officer), Chad Gassert (Senior Vice President, Corporate Development and Strategy), Ori Gutwerg (Senior Vice President, Generics), Thomas Haughey (Director), Nikhil Lalwani (Pres), Nikhil Lalwani (President and Chief Executive Officer), James Marken (Senior Vice President, Operations and Product Development), Christopher Mutz (Insider), Antonio Pera (Director), Muthusamy Shanmugam (Head of R&D and COO of NJ Operations), Muthusamy Shanmugam (Head of R&D and COO), Renee Tannenbaum (Director), Jeanne Thoma (Director), and Patrick Walsh (Director). Learn More on ANI Pharmaceuticals' active insiders.

Are insiders buying or selling shares of ANI Pharmaceuticals?

During the last year, insiders at the specialty pharmaceutical company sold shares 33 times. They sold a total of 268,126 shares worth more than $16,946,714.15. The most recent insider tranaction occured on March, 13th when VP Meredith Cook sold 400 shares worth more than $25,332.00. Insiders at ANI Pharmaceuticals own 12.7% of the company. Learn More about insider trades at ANI Pharmaceuticals.

Information on this page was last updated on 3/13/2025.

Chad Gassert Insider Trading History at ANI Pharmaceuticals

See Full Table

Chad Gassert Buying and Selling Activity at ANI Pharmaceuticals

This chart shows Chad Gassert's buying and selling at ANI Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$2M$0$2MTotal Insider BuyingTotal Insider Selling

ANI Pharmaceuticals Company Overview

ANI Pharmaceuticals logo
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Read More

Today's Range

Now: $67.61
Low: $67.02
High: $68.49

50 Day Range

MA: $60.49
Low: $54.51
High: $68.36

2 Week Range

Now: $67.61
Low: $52.50
High: $70.00

Volume

355,964 shs

Average Volume

256,304 shs

Market Capitalization

$1.47 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.63